China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval

Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 antibody testing an important supplement to nucleic acid testing. In the process of emergency approval, the Center for Medical Device Evaluation of the China National M...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Yunfeng, He, Jingyun, Liu, Rongzhi, Gao, Yu, Xu, Chao, Hu, Peng, Zheng, Shengwei, Fang, Li, Li, Ran, Han, Congyin, An, Juanjuan, Dong, Jinchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Newlands Press Ltd 2020
Materias:
Regulatory
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784785/
https://www.ncbi.nlm.nih.gov/pubmed/33326307
http://dx.doi.org/10.4155/bio-2020-0188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784785/
https://www.ncbi.nlm.nih.gov/pubmed/33326307
http://dx.doi.org/10.4155/bio-2020-0188

Ejemplares similares